Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 2
2003 4
2004 5
2006 3
2007 1
2008 4
2009 5
2010 7
2011 4
2012 3
2013 2
2014 1
2015 4
2016 3
2017 5
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.
Peck MW, Smith TJ, Anniballi F, Austin JW, Bano L, Bradshaw M, Cuervo P, Cheng LW, Derman Y, Dorner BG, Fisher A, Hill KK, Kalb SR, Korkeala H, Lindström M, Lista F, Lúquez C, Mazuet C, Pirazzini M, Popoff MR, Rossetto O, Rummel A, Sesardic D, Singh BR, Stringer SC. Peck MW, et al. Among authors: sesardic d. Toxins (Basel). 2017 Jan 18;9(1):38. doi: 10.3390/toxins9010038. Toxins (Basel). 2017. PMID: 28106761 Free PMC article. Review.
New adjuvants: EU regulatory developments.
Sesardic D, Rijpkema S, Patel BP. Sesardic D, et al. Expert Rev Vaccines. 2007 Oct;6(5):849-61. doi: 10.1586/14760584.6.5.849. Expert Rev Vaccines. 2007. PMID: 17931163 Review.
Detection of antibodies against botulinum toxins.
Sesardic D, Jones RG, Leung T, Alsop T, Tierney R. Sesardic D, et al. Mov Disord. 2004 Mar;19 Suppl 8:S85-91. doi: 10.1002/mds.20021. Mov Disord. 2004. PMID: 15027059 Review.
Human antibodies neutralizing diphtheria toxin in vitro and in vivo.
Wenzel EV, Bosnak M, Tierney R, Schubert M, Brown J, Dübel S, Efstratiou A, Sesardic D, Stickings P, Hust M. Wenzel EV, et al. Among authors: sesardic d. Sci Rep. 2020 Jan 17;10(1):571. doi: 10.1038/s41598-019-57103-5. Sci Rep. 2020. PMID: 31953428 Free PMC article.
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, Avril A, Pelat T, Urbain R, Fontayne A, Thullier P, Sesardic D, Lindström M, Hust M, Korkeala H. Derman Y, et al. Among authors: sesardic d. Toxins (Basel). 2016 Sep 12;8(9):257. doi: 10.3390/toxins8090257. Toxins (Basel). 2016. PMID: 27626446 Free PMC article.
A Cell Line for Detection of Botulinum Neurotoxin Type B.
Rust A, Doran C, Hart R, Binz T, Stickings P, Sesardic D, Peden AA, Davletov B. Rust A, et al. Among authors: sesardic d. Front Pharmacol. 2017 Nov 9;8:796. doi: 10.3389/fphar.2017.00796. eCollection 2017. Front Pharmacol. 2017. PMID: 29170639 Free PMC article.
Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
Miethe S, Rasetti-Escargueil C, Avril A, Liu Y, Chahboun S, Korkeala H, Mazuet C, Popoff MR, Pelat T, Thullier P, Sesardic D, Hust M. Miethe S, et al. Among authors: sesardic d. PLoS One. 2015 Oct 6;10(10):e0139905. doi: 10.1371/journal.pone.0139905. eCollection 2015. PLoS One. 2015. PMID: 26440796 Free PMC article.
53 results